PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel furer.rheum@gmail.com.\', \'Tel Aviv University Sackler Faculty of Medicine, Tel Aviv, Israel.\', \'Rheumatology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\', \'Rheumatology Unit, Carmel Hospital, Haifa, Israel.\', \'Medicine, Technion Israel Institute of Technology, Haifa, Israel.\', \'Rheumatology Unit, Hadassah University Hospital, Jerusalem, Israel.\', \'Internal Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\', \'The Hebrew University of Jerusalem Faculty of Medicine, Jerusalem, Jerusalem, Israel.\', \'Endocrinology Department, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1136/annrheumdis-2021-220647
?:hasPublicationType
?:journal
  • Annals of the rheumatic diseases
is ?:pmid of
?:pmid
?:pmid
  • 34127481
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 7.699
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all